The Food and Drug Administration recently approved Pfizer’s new treatment for a rare genetic bleeding disorder, marking a significant milestone for the company. The drug, known as Beqvez, is the first gene therapy from Pfizer to receive clearance in the United States. This innovative treatment is targeted towards adults with moderate to severe hemophilia B
0 Comments
In March, the latest data from the Commerce Department revealed that inflation continued to surge, with the personal consumption expenditures price index excluding food and energy increasing by 2.8% from a year ago. This figure matched the previous month’s rate, exceeding the Dow Jones consensus estimate of 2.7%. When including food and energy, the all-items
0 Comments
Recent developments in U.S.-China relations have highlighted the importance of cooperation and dialogue between the two global superpowers. In particular, the upcoming high-level talks on artificial intelligence (AI) signal a potential shift in the way technological advancements are approached and regulated on the world stage. The decision to hold the first U.S.-China intergovernmental dialogue on
0 Comments
Former Tesla executive Drew Baglino made headlines when he announced his resignation earlier this month. Along with this announcement, it was revealed that Baglino sold shares in the electric vehicle company worth approximately $181.5 million, as reported in a filing with the SEC. Baglino, who had been with Tesla since 2006, decided to sell about
0 Comments
In today’s digital age, social media has become an integral part of our daily lives. Healthcare professionals, including doctors, nurses, and medical students, are not exempt from its influence. The rise of platforms like X, TikTok, Instagram, Facebook, and LinkedIn has provided a new avenue for healthcare professionals to share their experiences, challenges, and successes
0 Comments